Improvement of Hepatitis C Virus (HCV) Genotype Determination with the New Version of the INNO-LiPA HCV Assay - Wikidata - awgldk - TriplyDB

Improvement of Hepatitis C Virus (HCV) Genotype Determination with the New Version of the INNO-LiPA HCV Assay

Improvement of Hepatitis C Virus (HCV) Genotype Determination with the New Version of the INNO-LiPA HCV Assay

http://www.wikidata.org/entity/Q27478358

about

Hepatitis C genotype 6: A concise review and response-guided therapy proposal Hepatitis C virus markers in infection by hepatitis C virus: In the era of directly acting antivirals Current molecular methods for the detection of hepatitis C virus in high risk group population: A systematic review Hepatitis C virus genotype 6: virology, epidemiology, genetic variation and clinical implication Differences between Two Real-Time PCR-Based Hepatitis C Virus (HCV) Assays (RealTime HCV and Cobas AmpliPrep/Cobas TaqMan) and One Signal Amplification Assay (Versant HCV RNA 3.0) for RNA Detection and Quantification Hepatitis C Virus (HCV) Genotype 1 Subtype Identification in New HCV Drug Development and Future Clinical Practice HCV genotyping from NGS short reads and its application in genotype detection from HCV mixed infected plasma High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods Factor VIII and IX deficiencies related to acquired inhibitors in a patient with chronic hepatitis C virus infection receiving treatment with pegylated interferon plus ribavirin.Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy.New insight into HCV E1/E2 region of genotype 4a.Reassessment of genotype 1 hepatitis C virus subtype misclassification by LiPA 2.0: implications for direct-acting antiviral treatment Molecular diagnostics in the management of chronic hepatitis C: key considerations in the era of new antiviral therapies.Hepatitis C virus genotype 7, a new genotype originating from central Africa.Comparison of Abbott RealTime HCV Genotype II with Versant line probe assay 2.0 for hepatitis C virus genotyping Prevalence of hepatitis C virus infections and distribution of hepatitis C virus genotypes among Korean blood donors.Evaluation of multiplex nested polymerase chain reaction for routine hepatitis C virus genotyping in egyptian patients Hepatitis C virus genotype 4 resistance and subtype demographic characterization of patients treated with ombitasvir plus paritaprevir/ritonavir.Evaluation of the Abbott Real Time HCV genotype II assay for Hepatitis C virus genotyping.High incidence of the hepatitis C virus recombinant 2k/1b in Georgia: Recommendations for testing and treatment Sequencing assays for failed genotyping with the versant hepatitis C virus genotype assay (LiPA), version 2.0.Consequences of inaccurate hepatitis C virus genotyping on the costs of prescription of direct antiviral agents in an Italian district.Tools for the diagnosis of hepatitis C virus infection and hepatic fibrosis staging.Hepatitis C virus RNA assays: current and emerging technologies and their clinical applications.Systematic review: epidemiology of hepatitis C genotype 6 and its management.Systematic review: Asian patients with chronic hepatitis C infection.Review article: the epidemiology and therapy of chronic hepatitis C genotypes 4, 5 and 6.Diagnosis and Management of Hepatitis C Virus Infection.Impact of HCV genotype on treatment regimens and drug resistance: a snapshot in time.ITPA gene polymorphism (94C>A) effects on ribavirin-induced anemia during therapy in Egyptian patients with chronic hepatitis C.Advances in the Diagnosis and Monitoring of Hepatitis C Virus Infection.Molecular Assay and Genotyping of Hepatitis C Virus among Infected Egyptian and Saudi Arabian Patients.Assessment of a Novel Automatic Real-Time PCR Assay on the Cobas 4800 Analyzer as a Screening Platform for Hepatitis C Virus Genotyping in Clinical Practice: Comparison with Massive Sequencing.Virology analyses of HCV genotype 4 isolates from patients treated with simeprevir and peginterferon/ribavirin in the Phase III RESTORE study.Diversity of 1,213 hepatitis C virus NS3 protease sequences from a clinical virology laboratory database in Marseille university hospitals, southeastern France.Characterization of Samples Identified as Hepatitis C Virus Genotype 1 without Subtype by Abbott RealTime HCV Genotype II Assay Using the New Abbott HCV Genotype Plus RUO Test.Introduction of an automated system for the diagnosis and quantification of hepatitis B and hepatitis C viruses.Characterization of hepatitis C virus intergenotypic recombinant strains and associated virological response to sofosbuvir/ribavirin.A complete molecular biology assay for hepatitis C virus detection, quantification and genotyping.Hepatitis C virus subtyping based on sequencing of the C/E1 and NS5B genomic regions in comparison to a commercially available line probe assay.

P2860

Q22305417-636EB73E-CA75-480D-8289-D3F9E4450CC6 Q26782033-42177E6F-4B59-4337-BBC4-02AAACCBD13F Q26851978-19E1420E-0AB7-4916-9847-0C7F12530A6F Q27024231-A41EFFA6-B86C-4FBA-B2A4-ACBEA4365D44 Q27487396-531342D1-8355-4FF7-A6A0-657B1DEC4255 Q27490447-30E03C2E-EFF3-455A-BDCF-2579E3733724 Q28545256-FA029733-E645-4485-8CD4-DD05CCDE6EE7 Q28652352-56C09973-E115-4472-836A-D9050CCB7906 Q33394560-E2AAE30B-D10F-47F6-A2E0-84B7F034B6EA Q34008754-C301D578-C36F-4DFD-9F94-AFE02351CD22 Q35005196-BC81AF11-E9AC-4B85-848C-2C713BABCB92 Q35036061-6AF574BD-5F52-4AF3-B04D-5AE6912B7793 Q35263756-D39C4893-AF5D-4B2B-9F5D-E5FDC624D224 Q35331109-6ADCC88D-0590-44FA-88DA-334382EA1CB0 Q35455627-5699E1ED-566F-426C-B03A-4850F9C236B1 Q35919852-E0015551-2EE5-4757-90B2-9F16A369BFB5 Q35990080-F13FAF22-6AF9-4626-A612-9F222F13F615 Q36158361-FF87478F-CEE9-4034-BFA3-70624F6D478D Q36270128-E5152F55-D541-4650-9A90-76856EB1F77F Q36676315-E751D127-45FE-4915-A6E3-6A15E5F105D5 Q37125237-EB1F4AF9-7D13-4F53-9783-C83B3E76CC4D Q37265764-3C918316-2BE7-4C16-8586-094A5C929535 Q37682493-EFDC60BF-B893-49E8-8E42-F70B00154A4E Q37822462-673FDC04-455E-4444-8EA6-47127C0F64A7 Q37882006-047939C5-FB4F-469B-A746-4F1A680FE0B1 Q38096012-5F1BE2A2-4365-4B63-9BDB-686E66DFE240 Q38164114-B4BCC9B2-1A3C-4E11-9816-CA1DA904389C Q38327430-4F1A2904-9E01-4906-A7EF-3F0E63E14CC9 Q38893104-052EA7D6-7347-4D68-9437-63240C33069A Q38985488-FFA77404-90D1-46CD-822D-B4B7431CC14D Q38992041-ABECEEE7-BB1C-462C-954E-2673C992EA8F Q40381500-CC1C6AD6-64DB-48B4-AC38-F5B06D099A8D Q40419604-430425CB-D737-42D5-B773-4C49A51251E7 Q40518926-3A66DF3F-1DF2-47FA-8580-0ED49A1F0C75 Q40955157-148D412E-2A0E-416E-8662-5AD3B4067DBB Q41114226-E82CCE54-157C-4C3A-9FFA-49F3A178F860 Q41809253-8388253F-0F9E-4A1F-87AD-614146F1701E Q42201573-01573EC8-FC0A-4DDE-80FA-D3A3FD289A5A Q42202988-E771B358-D3FB-495F-B5D6-9AE0D4B7EE16 Q42270437-035EFF7B-7F7F-46A8-90B1-B43ACB280943

P2860

Improvement of Hepatitis C Virus (HCV) Genotype Determination with the New Version of the INNO-LiPA HCV Assay

http://www.wikidata.org/entity/Q27478358

description

2007 nî lūn-bûn

@nan

2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Improvement of Hepatitis C Vir ...... ion of the INNO-LiPA HCV Assay

@ast

Improvement of Hepatitis C Vir ...... ion of the INNO-LiPA HCV Assay

@en

Improvement of Hepatitis C Vir ...... ion of the INNO-LiPA HCV Assay

@nl

type

label

Improvement of Hepatitis C Vir ...... ion of the INNO-LiPA HCV Assay

@ast

Improvement of Hepatitis C Vir ...... ion of the INNO-LiPA HCV Assay

@en

Improvement of Hepatitis C Vir ...... ion of the INNO-LiPA HCV Assay

@nl

prefLabel

Improvement of Hepatitis C Vir ...... ion of the INNO-LiPA HCV Assay

@ast

Improvement of Hepatitis C Vir ...... ion of the INNO-LiPA HCV Assay

@en

Improvement of Hepatitis C Vir ...... ion of the INNO-LiPA HCV Assay

@nl

P1433

Q27478358-E04B256F-3948-4592-A74A-A3C91126FB87

P1476

Q27478358-59732A37-6467-4A44-9AC0-2B93C5964B46

P2093

Q27478358-4C1B6D67-5AFC-41E0-B219-27A92EDED8C1

Q27478358-5D17E127-3977-446B-9283-8B4E06860C9D

Q27478358-71E11436-4D13-4337-AEBC-CF27B996EB89

Q27478358-92DDFF75-C779-42CB-B4E8-88A60DD239EB

Q27478358-BF692B60-F258-4A69-8147-8EFA12535599

Q27478358-FB7CD307-7964-408E-B611-C2EED2F7174F

P2860

Q27478358-014B52BE-7C92-4960-8E62-DFDC7B8B7A5A

Q27478358-0AA50D6F-3CD4-4629-BB9E-D1FDEAF7B1B1

Q27478358-0B903DC9-CCE4-4F9F-963D-C148441EE758

Q27478358-17268237-3821-48DE-99A4-ACBDD2FC94B2

Q27478358-19477CC1-2F0F-4DAB-86A7-6BBBEB5EB8AF

Q27478358-1BFB7235-3D84-4278-A9C5-652D7A305335

Q27478358-1CE102F3-97BA-4EE6-892D-C6954F96FBBF

Q27478358-208028E0-4916-4184-93EC-B0328E1100A1

Q27478358-2159EE58-CE94-4B8F-89E7-30CA4FB410E1

Q27478358-36E63403-F940-4415-9DF0-199C3D71C1CB

P304

Q27478358-6417753B-607A-4F74-8C5A-04FA8527210A

P31

Q27478358-E9C41F7D-3405-4F74-8E63-0C0B54F000A4

P3181

Q27478358-58CDC6A3-8909-4E4A-A4A3-52AEDF6A781D

P356

Q27478358-A88DE4DD-F417-45CD-9CAC-18050474BF20

P407

Q27478358-F7D96C2F-2302-4D53-9FEB-5B77D829F61D

P433

Q27478358-E7ACEFF4-0821-47A2-98CB-57C991DC8746

P478

Q27478358-12277044-6DCD-4D54-8866-8904D2D5D3A3

P50

Q27478358-0665FFAA-268C-4C52-ABDF-0E057EA4438B

Q27478358-7A3F9863-2823-4A7B-800E-89D2EEEB40F5

Q27478358-80C36859-C647-4F73-B594-E8A53995FADC

P577

Q27478358-13311152-0B02-4381-82D4-8EF75CB8EC80

P5875

Q27478358-B9E24FDC-7530-46D8-B1A1-47DB7E8B697C

P698

Q27478358-D7A2F7C3-B933-48FF-AE32-302C5CDFDC3B

P921

Q27478358-E24C783F-98A5-4F6F-8FFB-CF14A0F3ED68

P932

Q27478358-BBD34F3F-8252-4209-B45C-361C4D14F212

P3181

P356

P1433

Journal of Clinical Microbiology

P1476

Improvement of Hepatitis C Vir ...... ion of the INNO-LiPA HCV Assay

@en

P2093

Annie Razer

http://www.w3.org/2001/XMLSchema#string

Christine Portal

http://www.w3.org/2001/XMLSchema#string

Jean François Cantaloube

http://www.w3.org/2001/XMLSchema#string

Jean Michel Pawlotsky

http://www.w3.org/2001/XMLSchema#string

Philippe De Micco

http://www.w3.org/2001/XMLSchema#string

Stéphane Chevaliez

http://www.w3.org/2001/XMLSchema#string

P2860

CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice

Hepatitis C in a hemodialysis unit: molecular evidence for nosocomial transmission.

Confirmation of nosocomial transmission of hepatitis C virus by phylogenetic analysis of the NS5-B region

Hepatitis C virus genotyping: interrogation of the 5' untranslated region cannot accurately distinguish genotypes 1a and 1b

A Natural Intergenotypic Recombinant of Hepatitis C Virus Identified in St. Petersburg

Analysis of the 5' Noncoding Region versus the NS5b Region in Genotyping Hepatitis C Virus Isolates from Blood Donors in France

Hepatitis C Virus Subtyping by a Core-Envelope 1-Based Reverse Transcriptase PCR Assay with Sequencing and Its Use in Determining Subtype Distribution among Danish Patients

Clinical Evaluation of Two Methods for Genotyping Hepatitis C Virus Based on Analysis of the 5' Noncoding Region

Evaluation of a New Serotyping Assay for Detection of Anti-Hepatitis C Virus Type-Specific Antibodies in Serum Samples

Identification of a Naturally Occurring Recombinant Genotype 2/6 Hepatitis C Virus

P304

1140-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3525651

http://www.w3.org/2001/XMLSchema#string

P356

10.1128/JCM.01982-06

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P50

Françoise Bouchardeau

Jean-Jacques Lefrère

P577

2007-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6553070

http://www.w3.org/2001/XMLSchema#string

P698

17251399

http://www.w3.org/2001/XMLSchema#string

P921

P932

1865817

http://www.w3.org/2001/XMLSchema#string